Clofenciclan
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 2-[1-(4-chlorophenyl)cyclohexyl]oxy-N,N-diethylethanamine | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Routes | Oral |
| Identifiers | |
| CAS number | 5632-52-0 |
| ATC code | None |
| PubChem | CID 25904 |
| ChemSpider | 24135 |
| UNII | P4BVX0D2MX |
| Chemical data | |
| Formula | C18H28ClNO |
| Mol. mass | 309.874 |
| SMILES | eMolecules & PubChem |
|
|
| |
Clofenciclan (Chlorphencyclan; Tonquil, Vesitan) is a dopamine releasing agent developed by Boehringer & Soehne in the 1950s.[1] It proved unpopular as a treatment because of its pronounced stimulant activity.[2]
[edit] References
- ^ US Patent 3254083
- ^ Poeldinger W. Therapeutic experiences with thiopropazate and with a combination of thiopropazate and chlorphencyclan (Vesitan) in psychiatry. (German). Praxis. 1962 Jan 18;51:73-8. PMID 14487367
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |

